Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigmund Silber

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Nuklearmedizin. Nuclear Medicine|January 16, 2026
Nuclear cardiology - Current status of the clinical applicationOliver Lindner, Christian Goetz, Frank M Bengel, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 1, 2011
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatmentPieter R Stella, Anouar Belkacemi, Ron Waksman, et al.
Journal of the American College of Cardiology|February 18, 2014
4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)Masanori Taniwaki, Giulio G Stefanini, Sigmund Silber, et al.
European Journal of Preventive Cardiology|April 11, 2019
Impact of left ventricular function on clinical outcomes among patients with coronary artery diseaseGeorge Cm Siontis, Mattia Branca, Patrick Serruys, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 8, 2013
Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stentsPeter Bramlage, Alessandro Cuneo, Uwe Zeymer, et al.
Clinical Chemistry|December 14, 2011
Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary preventionDavid M Leistner, Jens Klotsche, Lars Pieper, et al.
JACC. Cardiovascular Interventions|March 24, 2012
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stentsGiulio G Stefanini, Bindu Kalesan, Thomas Pilgrim, et al.
JACC. Cardiovascular Interventions|November 21, 2015
Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 PatientsRaffaele Piccolo, Thomas Pilgrim, Dik Heg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 18, 2014
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary interventionPascal Vranckx, Bindu Kalesan, Giulio G Stefanini, et al.
European Journal of Preventive Cardiology|April 1, 2011
Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information?David M Leistner, Jens Klotsche, Sylvia Palm, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Nuklearmedizin. Nuclear Medicine|January 16, 2026
Nuclear cardiology - Current status of the clinical applicationOliver Lindner, Christian Goetz, Frank M Bengel, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 1, 2011
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatmentPieter R Stella, Anouar Belkacemi, Ron Waksman, et al.
Journal of the American College of Cardiology|February 18, 2014
4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)Masanori Taniwaki, Giulio G Stefanini, Sigmund Silber, et al.
European Journal of Preventive Cardiology|April 11, 2019
Impact of left ventricular function on clinical outcomes among patients with coronary artery diseaseGeorge Cm Siontis, Mattia Branca, Patrick Serruys, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 8, 2013
Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stentsPeter Bramlage, Alessandro Cuneo, Uwe Zeymer, et al.
Clinical Chemistry|December 14, 2011
Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary preventionDavid M Leistner, Jens Klotsche, Lars Pieper, et al.
JACC. Cardiovascular Interventions|March 24, 2012
Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stentsGiulio G Stefanini, Bindu Kalesan, Thomas Pilgrim, et al.
JACC. Cardiovascular Interventions|November 21, 2015
Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 PatientsRaffaele Piccolo, Thomas Pilgrim, Dik Heg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 18, 2014
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary interventionPascal Vranckx, Bindu Kalesan, Giulio G Stefanini, et al.
European Journal of Preventive Cardiology|April 1, 2011
Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information?David M Leistner, Jens Klotsche, Sylvia Palm, et al.
Pageof 20